Physician profile
Steven J Daniels
NPI 1215901608
$905.04
in general payments reported to CMS, 2019-2025
16 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $14.90 · 2021: $97.52 · 2022: $221 · 2023: $117 · 2024: $117 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $183.18 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novartis Pharmaceuticals Corporation | $155.94 | 2022-2025 | |
| Medtronic, INC. | $114.56 | 2022 | |
| Medtronic Vascular, INC. | $73.75 | 2019 | |
| Merck Sharp & Dohme LLC | $64.97 | 2022-2025 | Verquvo |
| Novo Nordisk INC | $54.75 | 2023-2025 | Wegovy, Ozempic |
| Pfizer INC. | $49.00 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $41.02 | 2020-2022 | |
| Boston Scientific Corporation | $31.40 | 2021 | |
| Cleerly, INC. | $28.04 | 2025 | Cleerly Labs, Cleerly Ischemia |
| E.R. Squibb & Sons, L.L.C. | $27.20 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.78 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $17.57 | 2025 | Onpattro |
| Heartflow, INC. | $16.19 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.55 | 2023 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.